ProMIS Neurosciences (PMN) Prepaid Assets (2021 - 2026)
ProMIS Neurosciences' (PMN) quarterly Prepaid Assets came in at $17510.0 in Q1 2026, down 99.67% YoY from $5.2 million in Q1 2025, and down 54.1% on a QoQ basis from $38150.0 in Q4 2025.
ProMIS Neurosciences (PMN) Prepaid Assets (2021 - 2026) Analysis & Trends
ProMIS Neurosciences (PMN) has 6 years of Prepaid Assets data on file, last reported at $17510.0 in Q1 2026.
- Quarterly Prepaid Assets fell 99.67% year-over-year to $17510.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17510.0 (down 99.67% YoY) and the FY2025 annual result came in at $38150.0, down 19.31% from the prior year.
- Prepaid Assets fell to $17510.0 in Q1 2026, from $38150.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $5.2 million in Q1 2025 to a low of $3385.0 in Q2 2023.
- A 5-year average of $863163.2 and a median of $40215.5 in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets plunged 99.72% — and 2025, when it surged 38217.46%.
- Tracing PMN's Prepaid Assets over 5 years: stood at $471088.0 in 2022, then plunged by 92.95% to $33217.0 in 2023, then surged by 42.34% to $47281.0 in 2024, then slipped by 19.31% to $38150.0 in 2025, then tumbled by 54.1% to $17510.0 in 2026.
- The last three Prepaid Assets figures came in at $17510.0 (Q1 2026), $38150.0 (Q4 2025), and $42281.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ProMIS Neurosciences | 132.34 Mn | 78.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.23 Mn |
| Mar 31, 2026 | 17,510.00 |
| Dec 31, 2025 | 38,150.00 |
| Sep 30, 2025 | 42,281.00 |
| Jun 30, 2025 | 4.97 Mn |
| Mar 31, 2025 | 5.25 Mn |
| Dec 31, 2024 | 47,281.00 |
| Sep 30, 2024 | 12,990.00 |
| Jun 30, 2024 | 12,961.00 |
| Mar 31, 2024 | 23,532.00 |
| Dec 31, 2023 | 33,217.00 |
| Sep 30, 2023 | 21,535.00 |
| Jun 30, 2023 | 3,385.00 |
| Mar 31, 2023 | 237,972.00 |
| Dec 31, 2022 | 471,088.00 |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | 1.23 Mn |
| Dec 31, 2021 | 4,387.00 |